FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab CNNOpinion | An Alzheimer’s Advance, Not a Cure-All The Wall Street JournalAdvisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug The New York TimesFDA panel votes unanimously for Eli Lilly’s Alzheimer’s treatment Yahoo Finance